ArticleChemical science2026
Direct-inject liquid-chromatography enables an autonomous continuous preferential crystallization platform.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Access to both enantiomers of chiral building blocks remains a fundamental challenge in chemical synthesis, particularly for scalable applications in pharmaceuticals, agrochemicals, and materials development. Continuous preferential crystallization (CPC) offers a promising route to obtain enantiomerically enriched compounds from racemic mixtures without the use of chiral auxiliaries. However, its widespread adoption is hindered by the need for precise supersaturation control mediated by real-time process analytical technologies capable of monitoring enantiomeric ratio. Here, we report the development of an autonomous CPC platform enabled by online chiral high-performance liquid chromatography. Using our Direct Inject Liquid Chromatography (DILC) module, we continuously monitor the crystallization process and implement feedback control that initiates temperature-based dissolution in response to early detection of undesired enantiomer accumulation. The trigger threshold is set from the measured noise in the baseline signal, so the controller responds to signal breakthrough rather than the scatter in the measurement, allowing it to run for days without supervision. Applied to the CPC of allylalanine monohydrate, a conglomerate-forming α-amino acid, this system achieved multi-day operation and gram-scale production of enantiopure material with minimal supervision. The platform establishes a generalizable strategy for real-time control of enantioselective crystallizations and opens new avenues for self-driving purification technologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.